The Bristol-Myers Squibb-Pfizer Alliance and Fitbit on Oct. 17 announced they’d be partnering to improve timely diagnosis of atrial fibrillation in people at an increased risk of stroke.

An implantable cardiac monitor designed to alert patients with coronary artery disease to progressive, abnormal ST-segment shifts could expedite transport to the ED and reduce treatment delays during acute coronary syndromes, according to work published in the Journal of the American College of Cardiology.

Despite a litany of bad press in recent months, a study published Oct. 17 in Addiction suggests e-cigarettes help some 50,000 smokers in the U.K. quit nicotine each year.

A study of more than 100,000 urban commuters in China suggests that walking or cycling to work can lower people’s risk of ischemic heart disease (IHD) and stroke, even when factoring in the “rather serious air pollution” in the country.

Consuming smaller amounts of alcohol more frequently is a greater risk factor for atrial fibrillation than binge drinking, according to a study published in EP Europace Oct. 17.

The FDA on Oct. 15 issued a warning letter to India-based Torrent Pharmaceuticals, targeting the drug company as one of the primary contributors to the onslaught of BP drug recalls in the past year.

A pooled analysis of 18 randomized trials has allowed researchers to unravel the so-called “smoker’s paradox,” proving that lighting up is an important risk factor for adverse events after PCI.

A study of thousands of individuals in Canada suggests the use of angiotensin receptor blockers—as opposed to ACE inhibitors—could be linked to an increased risk of suicide and poor mental health.